Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy
- PMID: 29568555
- PMCID: PMC5851186
- DOI: 10.1016/S2055-6640(20)30240-5
Report from the First EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children's Actual Life with Novel Immunotherapeutic Strategies) General Assembly meeting, 9-11 November 2017, Rome, Italy
Figures
References
-
- Chan M, Tagarro A, Zangari P et al. . Factors associated with HIV-DNA levels in children starting ART early in infancy. Conference on Retroviruses and Opportunistic Infections. March 2018. Boston, MA, USA.
-
- Violari A, Cotton M, Kuhn L et al. . Viral and host characteristics of a child with perinatal HIV-1 following a prolonged period after ART cessation in the CHER trial. International AIDS Society Conference. July 2017. Paris, France. Abstract TUPDB0106LB.
-
- Cotugno N, Morrocchi E, Pepponi I et al. . HIV specific IgM memory B cells dominate in seronegative early-treated children. Conference on Retroviruses and Opportunistic Infections. March 2018. Boston, MA, USA.
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources